Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
461.21
388.86
554.98
616.23
800.64
656.83
646.61
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
461.21
388.86
554.98
616.23
800.64
656.83
646.61
Raw Material Cost
277.15
203.23
286.97
287.99
412.48
373.12
320.57
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.92
5.25
5.57
5.19
7.33
7.97
7.28
Selling and Distribution Expenses
115.44
140.47
165.25
226.04
255.50
243.25
233.49
Other Expenses
2.84
4.52
1.81
1.99
1.97
3.60
2.25
Total Expenditure (Excl Depreciation)
422.93
394.17
475.91
539.11
695.02
660.35
583.82
Operating Profit (PBDIT) excl Other Income
38.3
-5.300000000000001
79.1
77.1
105.60000000000001
-3.5
62.800000000000004
Other Income
8.55
12.70
16.74
19.57
20.37
236.47
21.30
Operating Profit (PBDIT)
43.64
35.00
141.11
140.00
174.21
62.37
142.45
Interest
1.92
5.25
5.57
5.19
7.33
7.97
7.28
Exceptional Items
0.06
-32.75
0.01
0.00
0.00
0.09
0.08
Gross Profit (PBDT)
184.06
185.63
268.01
328.25
388.15
283.71
326.04
Depreciation
0.00
50.55
50.55
49.03
49.03
61.36
61.36
Profit Before Tax
41.78
-53.55
84.99
85.78
117.84
-6.87
73.90
Tax
3.69
-6.76
10.50
9.37
20.92
34.12
5.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
69.05
-21.77
85.13
93.98
122.50
-19.97
90.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
69.05
-21.77
85.13
93.98
122.50
-19.97
90.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.25
-1.98
1.24
-0.73
-0.19
-0.40
-0.16
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
68.80
-23.75
86.37
93.24
122.31
-20.37
90.79
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,445.51
4,395.88
4,399.80
4,318.67
4,276.08
4,144.81
4,149.72
Earnings per share (EPS)
0.06
-0.02
0.07
0.08
0.1
-0.02
0.08
Diluted Earnings per share
0.06
-0.02
0.07
0.08
0.1
-0.02
0.08
Operating Profit Margin (Excl OI)
7.61%
-7.27%
13.3%
11.59%
13.09%
-35.85%
9.25%
Gross Profit Margin
9.06%
-0.77%
24.42%
21.88%
20.84%
8.3%
20.92%
PAT Margin
14.97%
-5.6%
15.34%
15.25%
15.3%
-3.04%
14.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2025 is 18.59% vs -29.93% in Dec 2024
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2025 is 390.30% vs -127.43% in Dec 2024
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2025 is 57.40% vs -82.07% in Dec 2024
Interest
QoQ Growth in quarter ended Mar 2025 is -63.46% vs -7.14% in Dec 2024
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024
Compare Quarterly Results Of Fuan Pharmaceutical (Group) Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
461.21
0
461.21
Other Operating Income
0.00
0.00
0.00
Total Operating income
461.21
0
461.21
Raw Material Cost
277.15
0
277.15
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.92
0
1.92
Selling and Distribution Expenses
115.44
0
115.44
Other Expenses
2.84
0.00
2.84
Total Expenditure (Excl Depreciation)
422.93
0
422.93
Operating Profit (PBDIT) excl Other Income
38.28
0.00
38.28
Other Income
8.55
0
8.55
Operating Profit (PBDIT)
43.64
0
43.64
Interest
1.92
0
1.92
Exceptional Items
0.06
0
0.06
Gross Profit (PBDT)
184.06
0
184.06
Depreciation
0.00
0
0.00
Profit Before Tax
41.78
0
41.78
Tax
3.69
0
3.69
Provisions and contingencies
0
0
0.00
Profit After Tax
69.05
0
69.05
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
69.05
0
69.05
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.25
0
-0.25
Other related items
0.00
0.00
0.00
Consolidated Net Profit
68.80
0
68.80
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,445.51
0
4,445.51
Earnings per share (EPS)
0.06
0
0.06
Diluted Earnings per share
0.06
0
0.06
Operating Profit Margin (Excl OI)
7.61%
0%
0.00
7.61%
Gross Profit Margin
9.06%
0%
0.00
9.06%
PAT Margin
14.97%
0%
0.00
14.97%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 46.12 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is 18.59% vs -29.93% in Dec 2024
YoY Growth in quarter ended Mar 2025 is -42.39% vs 16.84% in Mar 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.88 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is 390.30% vs -127.43% in Dec 2024
YoY Growth in quarter ended Mar 2025 is -43.74% vs 38.51% in Mar 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.51 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is 57.40% vs -82.07% in Dec 2024
YoY Growth in quarter ended Mar 2025 is -77.18% vs 34.44% in Mar 2024
Quarterly - Interest
Interest 0.19 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is -63.46% vs -7.14% in Dec 2024
YoY Growth in quarter ended Mar 2025 is -73.97% vs 12.31% in Mar 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.61%
in Mar 2025Figures in %
QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024
YoY Growth in quarter ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
